News

NORD Announces Rare Disease Research Funding Opportunities


 

References

The National Organization for Rare Disorders (NORD) has posted requests for proposals (RFPs) for grants to support research on several rare diseases. July 31, 2015, will be the deadline to submit abstracts and letters of intent. The RFPs are posted on the NORD website (www.rarediseases.org). Diseases for which funding is available in this cycle are: alveolar capillary dysplasia, autoimmune polyglandular syndrome type 1, pseudomyxoma peritonei, cat eye syndrome, Creutzfeldt-Jakob disease, homocystinuria due to cystathionine beta synthase deficiency, lysosomal storage diseases, and complement-related diseases. All decisions regarding funding are made by the NORD Scientific and Medical Advisory Committee. Questions may be directed to jkraska@rarediseases.org.

Recommended Reading

Cystic fibrosis–related diabetes requires different approach
MDedge Endocrinology
ILC: NAFLD a stealth trigger of hepatocellular carcinoma
MDedge Endocrinology
ASA: Mutation testing aids decision making in thyroid cancer
MDedge Endocrinology
Canada Adopts First-Ever Rare Disease Strategy
MDedge Endocrinology
NORD Issues Statement on Approval of 21st Century Cures Initiative and Introduction of OPEN Act
MDedge Endocrinology
Foundation for Prader-Willi Research and NORD Launch Global Registry
MDedge Endocrinology
NORD, EURORDIS, and Rare Disease Organizations in 30 Nations Announce an International Rare Diseases Alliance (copy 1)
MDedge Endocrinology
NIH Will Not Fund Gene-Editing Technologies in Human Embryos
MDedge Endocrinology
Drug Approved for LAM Illustrates How Patient Organizations Can Partner With Researchers
MDedge Endocrinology
Pediatric Endocrine Society Publishes Guidelines for Evaluation and Management of Persistent Hypoglycemia
MDedge Endocrinology